3623 results for «2622»
3623 results
Tailoring mitral repair: new evidence demonstrating improved patient outcomes
27 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to tailor the mitral valve repair and optimise treatment based on etiology and mitral valve anatomy and to learn about current MitraClip clip options as well as look into the future of the mitral repair treatment.
Hotlines and innovations on stable CAD - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of stable CAD:
- ANGIE trial
- Prevention of AKI with sodium bicarbonate
- AI-based plaque characterisation
Coronary Microvascular Dysfunction: Why diagnosis in the Cathlab does matter
26 Jun 2020 – From PCR e-Course 2020
Watch this session to learn more about the prevalence of coronary microvascular dysfunction & angina, and to learn why diagnosis of coronary microvascular dysfunction is so important.
Hotlines and innovations on bifurcation lesions - PCR e-Course 2020
View this hot line from PCR e-Course 2020 on the topic of bifurcation stenting regarding the role of deployment technique in a global registry.
One-year TRILUMINATE trial results
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn more about the key findings of the TRILUMINATE 1 year outcome.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Hotlines and innovations on other coronary interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:
- Gender differences in outcomes after rational atherectomy PCI
- Intensified antiplatelet therapy in post-PCI patients with HOPR
Selection of appropriate devices for retrograde CTO cases
25 Jun 2020 – From PCR e-Course 2020
Watch this roundtable discussion if you want to witness appropriate device selection for retrograde approach, to improve your skills as a CTO operator and to have interactive discussions about available chronic total occlusion wires and devices.
Hotlines and innovations on valve interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:
- Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
- Quantitative angiographic assessment of MR after mitral procedures
To stent or not to stent? Discussion of complex PCI cases
26 Jun 2020 – From PCR e-Course 2020
Watch this roundtable discussion if you want to join a detailed discussion about the drug-eluting stent vs. drug-coated balloon approach, to discuss the importance of lesion preparation for optimal coronary intervention results and to share insights about state-of-the-art treatment options from leading expert.
Hotlines and innovations on STEMI - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of STEMI:
- Stenosis Severity and Complete Revascularisation in STEMI
- Analysis of changes in decision-making process during OCT-guided PCI
Current evidence for the interventional treatment of INOCA patients
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.
Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to understand how intravascular lithotripsy works through real-world cases, to hear from global leading physicians about where intravascular lithotripsy fits into their clinical practice and to hear about some of the most prominent cases of coronary intravascular lithotripsy.
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
Crossover results from the RADIANCE-HTN SOLO trial
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.
Videos included on this page: the Hot Line presentation, an...
Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?
25 Jun 2020 – From PCR e-Course 2020
Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.
Videos included on this page: the abstract presentation and an Investigator Perspective.
Update on the regulation of high-risk medical devices: a transatlantic perspective
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.
This session was originally presented during PCR...
PICSO improves coronary microvascular function in patients with STEMI
25 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.
Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
